How do I convert a dose of 30 mg for a 70‑kg patient (hm 30/70) to the hematologic risk index (HRI) and the number of hours (NOH)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Understanding the Question

The question "How to convert hm(30/70) dose to HRI AND NOH" appears to contain a notation error or miscommunication. After reviewing all available evidence, there is no established medical terminology or dosing system that uses "hm(30/70)" in relation to "HRI" (Hematologic Risk Index) or "NOH" (Number of Hours).

What the Evidence Actually Addresses

The provided evidence focuses on:

  • Heparin dosing for acute coronary syndromes, PCI, and anticoagulation 1, 2, 3
  • Antihypertensive medications in pediatric populations 1
  • Opioid conversion ratios between different formulations 4, 5
  • General pharmacokinetic dosing adjustments 6
  • Metric unit standardization for oral liquid medications 7

None of these sources define or reference "hm(30/70)", "HRI", or "NOH" as dosing parameters or conversion systems.

Possible Interpretations (All Unsupported by Evidence)

The notation could theoretically represent:

  1. A heparin mixture ratio (30%/70%), but this is not a standard clinical formulation 1
  2. A weight-based calculation (30 mg for 70 kg patient), but "HRI" and "NOH" are not recognized conversion targets in any guideline 2, 3
  3. An insulin mixture (30/70 formulation), but the question mentions conversion to indices not used in diabetes management
  4. A local institutional protocol using non-standard abbreviations

Critical Clinical Guidance

If this question pertains to anticoagulation dosing:

  • For unfractionated heparin in acute coronary syndrome, use 60 U/kg IV bolus (maximum 4,000 units) followed by 12 U/kg/hour infusion (maximum 1,000 units/hour), adjusted to maintain aPTT at 1.5-2.0 times control 2
  • For PCI without prior anticoagulation, use 70-100 U/kg IV bolus to achieve ACT of 250-350 seconds 1, 2

If this question pertains to medication conversion:

  • All dose conversions require knowing the specific drug, route of administration, patient weight, renal function, and clinical indication 6, 4, 5
  • Weight-based dosing should always use metric units (mg/kg) rather than household or non-standard measurements 7

Recommendation

The question as written cannot be answered using evidence-based medicine because "hm(30/70)", "HRI", and "NOH" are not recognized medical terminology in any published guideline or research. 1, 2, 3, 7, 6, 8, 4, 5

To provide accurate guidance, please clarify:

  • The specific medication or intervention being dosed
  • The clinical indication (anticoagulation, analgesia, antihypertensive therapy, etc.)
  • The patient's weight, age, and renal function
  • What "HRI" and "NOH" represent in your institutional or regional practice

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Heparin Infusion Duration for Acute Coronary Syndrome Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Heparin Anticoagulation for Aortic Cross‑Clamping

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2024

Research

Shortcut formulae for pharmacokinetic dosage adjustments.

Clinical pharmacokinetics, 2009

Research

NCPDP recommendations for standardizing dosing in metric units (mL) on prescription container labels of oral liquid medications, version 2.0.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2021

Research

Medical Imaging and Pediatric and Adolescent Hematologic Cancer Risk.

The New England journal of medicine, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.